Superti-Furga G - Search Results

1

Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.

Remsing Rix LL, Rix U, Colinge J, Hantschel O, Bennett KL, Stranzl T, Müller A, Baumgartner C, Valent P, Augustin M, Till JH, Superti-Furga G. Remsing Rix LL, et al. Leukemia. 2009 Mar;23(3):477-85. doi: 10.1038/leu.2008.334. Epub 2008 Nov 27. Leukemia. 2009. PMID: 19039322

2

A functional screen for regulators of the c-Abl protein tyrosine kinase.

Moro M, Walkenhorst J, Goga A, Witte ON, Superti-Furga G. Moro M, et al. Leukemia. 1997 Apr;11 Suppl 3:313-5. Leukemia. 1997. PMID: 9209375

3

A myristoyl/phosphotyrosine switch regulates c-Abl.

Hantschel O, Nagar B, Guettler S, Kretzschmar J, Dorey K, Kuriyan J, Superti-Furga G. Hantschel O, et al. Cell. 2003 Mar 21;112(6):845-57. doi: 10.1016/s0092-8674(03)00191-0. Cell. 2003. PMID: 12654250 Free article.

4

Structural basis for the autoinhibition of c-Abl tyrosine kinase.

Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, Clarkson B, Superti-Furga G, Kuriyan J. Nagar B, et al. Cell. 2003 Mar 21;112(6):859-71. doi: 10.1016/s0092-8674(03)00194-6. Cell. 2003. PMID: 12654251 Free article.

5

Regulation of the c-Abl and Bcr-Abl tyrosine kinases.

Hantschel O, Superti-Furga G. Hantschel O, et al. Nat Rev Mol Cell Biol. 2004 Jan;5(1):33-44. doi: 10.1038/nrm1280. Nat Rev Mol Cell Biol. 2004. PMID: 14708008 Review.

6

Structural basis for the cytoskeletal association of Bcr-Abl/c-Abl.

Hantschel O, Wiesner S, Güttler T, Mackereth CD, Rix LL, Mikes Z, Dehne J, Görlich D, Sattler M, Superti-Furga G. Hantschel O, et al. Mol Cell. 2005 Aug 19;19(4):461-73. doi: 10.1016/j.molcel.2005.06.030. Mol Cell. 2005. PMID: 16109371 Free article.

7

Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.

Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, Kuriyan J. Nagar B, et al. Mol Cell. 2006 Mar 17;21(6):787-98. doi: 10.1016/j.molcel.2006.01.035. Mol Cell. 2006. PMID: 16543148 Free article.

8

An efficient tandem affinity purification procedure for interaction proteomics in mammalian cells.

Bürckstümmer T, Bennett KL, Preradovic A, Schütze G, Hantschel O, Superti-Furga G, Bauch A. Bürckstümmer T, et al. Nat Methods. 2006 Dec;3(12):1013-9. doi: 10.1038/nmeth968. Epub 2006 Oct 22. Nat Methods. 2006. PMID: 17060908

9

The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.

Hantschel O, Rix U, Schmidt U, Bürckstümmer T, Kneidinger M, Schütze G, Colinge J, Bennett KL, Ellmeier W, Valent P, Superti-Furga G. Hantschel O, et al. Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13283-8. doi: 10.1073/pnas.0702654104. Epub 2007 Aug 7. Proc Natl Acad Sci U S A. 2007. PMID: 17684099 Free PMC article.

10

Selective serotonin reuptake inhibitors--a new modality for the treatment of lymphoma/leukaemia?

Schuster C, Fernbach N, Rix U, Superti-Furga G, Holy M, Freissmuth M, Sitte HH, Sexl V. Schuster C, et al. Biochem Pharmacol. 2007 Nov 1;74(9):1424-35. doi: 10.1016/j.bcp.2007.07.017. Epub 2007 Jul 20. Biochem Pharmacol. 2007. PMID: 17709099 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page